カルモジュリン変異は,乳児における再発性心停止と関連しています
Lia Crotti1, Christopher N Johnson, Elisabeth Graf
1Section of Cardiology, Department of Molecular Medicine, University of Pavia, Pavia, Italy.
Circulation
|February 8, 2013
まとめ
カルモジュリン遺伝子の変異 (CALM1,CALM2) は,生命を脅かす乳児の心臓発作や心律不整を引き起こします. これらの遺伝的欠陥は,カルシウム結合を阻害し,心拍の調節を妨げます.
科学分野:
- 遺伝学 遺伝学とは
- 心臓病学 心臓病学
- 分子生物学は分子生物学である.
背景:
- 幼児の心停止は,突然の悲劇的な死につながる可能性があります.
- これらの生命を脅かす心臓リズム障害の遺伝的原因は,しばしば不明です.
研究 の 目的:
- 2人の無縁の乳児の再発性心停止の遺伝的原因を特定するために.
- 特定された突然変異の機能的影響を調査する.
主な方法:
- エクソームシーケンシングは,2つの乳児と親のトリオで実施されました.
- 候補遺伝子のスクリーニングは,先天性QT長症候群の患者の追加のコホートで行われました.
- 生物化学の研究では,カルモジュリンのカルシウム結合に対する突然変異の影響を分析した.
主要な成果:
- 再発性心停止の乳児において,CALM1またはCALM2の3つのヘテロジゴスなde novo変異が特定されました.
- 変異媒介者は,生命を脅かす心室動脈不律症,,神経発達遅延を発症した.
- 変異したカルモドゥリンは,カルシウム結合親和性が著しく低下したことを示した.
結論:
- 人間のカルモジュリンの変異は,カルシウム結合を妨害し,重度の乳児状態につながります.
- カルモジュリン機能障害は,心臓におけるカルシウムシグナル伝達に影響を与え,致命的な心律失調を引き起こします.
- これは,突然の乳児死亡症候群のための新しい遺伝的メカニズムを特定します.
関連する概念動画
01:16Calmodulin-dependent Signaling
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
01:28Mechanism of Cardiac Arrhythmias
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
01:25Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...